FDA Approves Prior Approval Supplement for BIVIGAM®
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/18/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
| ADMA Biologics Inc Com (NASDAQ: ADMA) | Delayed: 10.68 -0.05 (0.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.73 | 52 Week High | $9.65 | |||
| Open | $10.73 | 52 Week Low | $4.15 | |||
| Day High | $10.87 | P/E | N/A | |||
| Day Low | $10.61 | EPS | $-0.01 | |||
| Volume | 3,073,728 | |||||
